Polley, Mei-Yin C. http://orcid.org/0000-0003-0106-0323
Dickler, Maura N.
Sinnwell, Jason
Tenner, Kathleen
de la Haba, Juan
Loibl, Sibylle
Goetz, Matthew P.
Bergh, Jonas
Roberston, John
Couch, Fergus
Ellis, Matthew J.
Martin, Miguel
Funding for this research was provided by:
National Cancer Institute (P50 CA116201, P50 CA116201, P50 CA116201)
Article History
Received: 22 March 2021
Accepted: 26 June 2021
First Online: 3 July 2021
Declarations
:
: Dr. Martin reports research Grants from Roche, PUMA and Novartis, consulting/advisory fees from AstraZeneca, Amgen, Taiho Oncology, Roche/Genentech, Novartis, PharmaMar, Eli Lilly, PUMA, Taiho Oncology, Daiichi Sankyo and Pfizer and speakers’ honoraria from AstraZeneca, Amgen, Roche/Genentech, Novartis, and Pfizer. Dr. Goetz reports personal fees from Genomic Health, consulting fees from Lilly, Biovica, Novartis, Sermonix, Context Pharm, Pfizer, Biotheranostics, and grants from Pfizer, Lilly, and Sermonix.
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
: The need for obtaining informed consent was waived by the institutional review board, given that this study was retrospective and non-interventional.